Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global VPM Market Portraiture
2.2. Global VPM Market, by Type of Product, 2017 (US$ Mn)
2.3. Global VPM Market, by Type of Application, 2017 (US$ Mn
2.4. Global VPM Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global Veterinary Pain Management (VPM) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Increasing prevalence of degenerative diseases in pets & farm animals
3.2.2. Rising awareness related to the diagnosis & treatment of pain-inducing diseases & conditions
3.3. Challenges
3.3.1. Lack of early diagnosis & minimum penetration in rural & remote parts of South America, Asia & Africa
3.4. Opportunities
3.4.1. Ongoing technological advancements in the field of veterinary diagnosis & treatment expected to assist the growth & penetration of VPM market
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Drugs
4.2.1. Opioids
4.2.2. α2-adrenergic Agonists
4.2.3. Local Anesthetics
4.2.4. Nonsteroidal Anti-inflammatory Drugs (NSIDs)
4.2.5. Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
4.2.6. Others (Sedatives, Corticosteroids etc.)
4.3. Devices
4.3.1. Laser Therapy
4.3.2. Electromagnetic Therapy
Chapter 5. Global Veterinary Pain Management (VPM) Market, by Type of Application, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Degenerative diseases (e.g., osteoarthritis, Cushing’s disease)
5.3. Post-surgical orthopedic complexities
5.4. Neurologic impairments
5.5. Chronic musculoskeletal laxity
5.6. Dermatologic diseases
5.7. Postchemotherapy gastrointestinal disease
Chapter 6. Global Veterinary Pain Management (VPM) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America VPM Market Analysis, 2016 – 2026
6.2.1. North America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.2.2. North America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.2.3. North America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe VPM Market Analysis, 2016 – 2026
6.3.1. Europe VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.3.2. Europe VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.3.3. Europe VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific VPM Market Analysis, 2016 – 2026
6.4.1. Asia Pacific VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America VPM Market Analysis, 2016 – 2026
6.5.1. Latin America VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.5.2. Latin America VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.5.3. Latin America VPM Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) VPM Market Analysis, 2016 – 2026
6.6.1. Middle East & Africa VPM Market, by Type of Product, 2016–2026 (US$ Mn)
6.6.2. Middle East & Africa VPM Market, by Type of Application, 2016–2026 (US$ Mn)
6.6.3. MEA VPM Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Boehringer Ingelheim
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Zoetis
7.3. Elanco
7.4. Merck Animal Health
7.5. Bayer
7.6. Vetoquinol
7.7. Norbrook Laboratories
7.8. Ceva Santé Animale
7.9. Dechra Pharmaceuticals
7.10. Chanelle
7.11. K-Laser USA
7.12. Assisi Animal Health
List of Figures
FIG. 1 Veterinary Pain Management (VPM): Market Segmentation
FIG. 2 Global VPM Market Share, by Type of Product, 2017 (US$ Mn)
FIG. 3 Global VPM Market Share, by Type of Application, 2017 (US$ Mn)
FIG. 4 Global VPM Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Opioids Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 8 Global α2-adrenergic Agonists Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 9 Global Local Anesthetics Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for VPM Market, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Drugs Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 13 Global Laser Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 14 Global Electromagnetic Therapy Devices Market for VPM, 2016 – 2026 (US$ Mn)
FIG. 15 Global VPM Market for Degenerative Diseases, 2016 – 2026 (US$ Mn)
FIG. 16 Global VPM Market for Post-surgical Orthopedic Complexities, 2016 – 2026 (US$ Mn)
FIG. 17 Global VPM Market for Neurologic Impairments, 2016 – 2026 (US$ Mn)
FIG. 18 Global VPM Market for Chronic Musculoskeletal Laxity, 2016 – 2026 (US$ Mn)
FIG. 19 Global VPM Market for Dermatologic Diseases, 2016 – 2026 (US$ Mn)
FIG. 20 Global VPM Market for Post-chemotherapy Gastrointestinal Disease, 2016 – 2026 (US$ Mn)
FIG. 21 U.S. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Canada VPM Market, 2016 – 2026 (US$ Mn)
FIG. 23 U.K. VPM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Germany VPM Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest Of Europe VPM Market, 2016 – 2026 (US$ Mn)
FIG. 26 Japan VPM Market, 2016 – 2026 (US$ Mn)
FIG. 27 China VPM Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest Of Asia Pacific VPM Market, 2016 – 2026 (US$ Mn)
FIG. 29 Brazil VPM Market, 2016 – 2026 (US$ Mn)
FIG. 30 Mexico VPM Market, 2016 – 2026 (US$ Mn)
FIG. 31 Rest Of Latin America VPM Market, 2016 – 2026 (US$ Mn)
FIG. 32 GCC VPM Market, 2016 – 2026 (US$ Mn)
FIG. 33 Rest Of Middle East And Africa VPM Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Veterinary Pain Management (VPM) Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 3 North America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 4 North America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 5 North America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 Europe VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 7 Europe VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 8 Europe VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America VPM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East & Africa VPM Market, by Type of Product, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East & Africa VPM Market, by Type of Application, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa VPM Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Elanco: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Bayer: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Vetoquinol: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Norbrook Laboratories : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Ceva Santé Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Dechra Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Chanelle: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 K-Laser USA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Assisi Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)